OAC monotherapy offers optimal balance for secondary prevention in atrial fibrillation and stroke patients compared to combination strategies
Taking one blood thinner alone works best for heart and stroke patients compared to mixing medicines
A network meta-analysis of 14,104 patients suggests oral anticoagulant monotherapy is the most favorable strategy for secondary prevention i…
Doctors found that using just one blood thinner is safer and more effective than mixing it with other pills. This approach lowers stroke ris…
Meta-analysis shows association between tirofiban and improved functional outcomes in non-LVO acute ischemic stroke
Tirofiban May Help More Stroke Patients Walk and Talk After 90 Days
This meta-analysis of 3,225 patients evaluated the association between tirofiban and conventional antiplatelet therapy for acute ischemic st…
A stroke drug called tirofiban may help more people recover fully after 90 days, especially when used with standard clot-busting treatment.
Asundexian added to antiplatelet therapy reduces recurrent stroke risk without increasing major bleeding in high-risk patients
New drug lowers stroke risk in high-risk patients without increasing bleeding
This phase 3 trial evaluated asundexian added to standard antiplatelet therapy in patients with noncardioembolic ischemic stroke or high-ris…
A new daily pill lowers stroke risk in high-risk patients without increasing bleeding, offering a safer option for preventing clots after a …
Systematic review finds low-certainty evidence against endovascular therapy superiority in vertebral artery stenosis
Stents May Not Stop Strokes in Narrowed Neck Arteries
This systematic review evaluated endovascular therapy versus medical treatment alone in adults with symptomatic vertebral artery stenosis.
Stents might not stop strokes in narrowed neck arteries better than medicine alone for people with blocked blood flow to the back of the bra…